Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics
Linking anemia to inflammation and cancer: The crucial role of TNFα
Impact of alendronate and VEGF-antisense combined treatment on highly VEGF-expressing A431 cells
The kinase inhibitor O 6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK2
Ras inhibition attenuates myocardial ischemia-reperfusion injury
Analogs of MK-499 are differentially affected by a mutation in the S6 domain of the hERG K+ channel
Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo
Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose
Disposition of everolimus in mdr1a-/1b- mice and after a pre-treatment of lapatinib in Swiss mice
hSET1: A novel approach for colon cancer therapy
In vitro studies on the metabolism of trabectedin (YONDELIS®) in monkey and man, including human CYP reaction phenotyping